comparemela.com

Latest Breaking News On - Agictouch - Page 1 : comparemela.com

Concept Medicals fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

PRNewswire, Tampa (Florida) [US], May 29: The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Sirolimus Coated Balloon (SCB) for the treatment of Superficial Femoral Arteries (SFA).

United statesInvestigational device exemptionSirolimus coated balloonSuperficial femoral arteriesConcept medicals fourth ide approval for the magictouch sirolimus coated balloon is granted treatment of superficial femoral artery disease sfa

Concept Medical Inc : Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

TAMPA, Fla., May 1, 2023 /PRNewswire/ The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's novel MagicTouch Sirolimus Coated Balloon (SCB) for

United statesCardiovascular research foundationConcept medical incInvestigational device exemptionMagictouch sirolimus coated balloonSmall vesselsCoated balloonSmall vesselConcept medicalSirolimus coated balloonIn stent restenosisVessel diseaseDrug coated balloonsDrug eluting stentsHybrid bifurcationMartin leon

Concept Medical: MagicTouch SCB receives IDE approval for In-Stent Restenosis indication

TAMPA, Fla., Sept. 17, 2022 /PRNewswire/ The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch Sirolimus Coated Balloon (SCB) indicated for In-Stent Restenosis

United statesConcept medical incInvestigational device exemptionMagictouch sirolimus coated balloonIn stent restenosisSirolimus coated balloonConcept medical

vimarsana © 2020. All Rights Reserved.